The US Food and Drug Administration said on Thursday it has banned more products from Indian drugmaker Ranbaxy Laboratories Limited from entering the United States due to manufacturing violations.......
Shares in Ranbaxy Laboratories closed the day down around 4 per cent at Rs 445.20 after Sun Pharmaceutical Industries said it will buy the company in a $3.2 billion all-share deal, creating the......
Indian drugmaker Ranbaxy Laboratories Ltd, reeling under a flurry of regulatory rebukes due to manufacturing quality concerns, has recalled more than 64,000 bottles of the generic version of a......
The department of pharmaceuticals under the ministry of chemicals and fertilisers has proposed that the government set up an expert group to assess the impact of foreign direct investment in this......
The Indian Pharmaceutical Alliance, the association of the country's leading domestic drug producers, has sounded the alarm bells against foreign companies acquiring homegrown players. In fact, it......